Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38232

AP3S1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CRISPR/Cas9-edited polyclonal HEK293T cells with knockout of AP3S1, the gene encoding the sigma subunit of the AP-3 adaptor complex. Disruption of AP3S1 impairs AP-3 complex assembly, leading to defective sorting of transmembrane cargoes such as LAMP-1 and TYRP1 from the trans-Golgi network to lysosomes and melanosomes, recapitulating cellular defects of Hermansky-Pudlak syndrome type 2. This model is suitable for trafficking and lysosome biogenesis studies. The polyclonal format provides a heterogeneous knockout population ideal for pooled functional assays, including Western blotting, immunofluorescence, and co-immunoprecipitation experiments. HEK293T cells enable robust protein expression and rapid genetic manipulation, facilitating investigation of AP-3-related pathways and disease modeling. Contact Ascent Research for product details.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    AP3S1

    Gene Identifier

    NCBI Gene ID 1176

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The AP3S1 Knockout HEK293T Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population targeting the AP3S1 gene, which encodes the sigma subunit of the heterotetrameric adaptor protein complex-3 (AP-3). This gene-disrupted pool in the HEK293T background serves as a versatile loss-of-function model for studying the role of AP3S1 in intracellular trafficking and organelle biogenesis. As a polyclonal population, it retains the inherent cellular heterogeneity of a bulk knockout, suitable for pooled phenotypic and biochemical analyses without clonal bias.

The HEK293T host cell line is a human embryonic kidney derivative that constitutively expresses the SV40 large T-antigen. This expression enables episomal replication of plasmids bearing the SV40 origin, supporting high-level transient protein production and efficient lentiviral and retroviral packaging. HEK293T cells are widely employed in gene expression, signal transduction, and membrane trafficking studies due to their high transfectability, rapid growth, and well-characterized endosomal?Clysosomal system.

AP3S1 is an essential component of the AP-3 adaptor complex, which also includes the ?? (AP3D1), ??3 (AP3B1), and ??3 (AP3M1) subunits. The complex is recruited to the trans-Golgi network by the small GTPase ARF1 and the scaffold protein clathrin, where it selects transmembrane cargo proteins??such as LAMP-1, LAMP-2, TYRP1, and CD63??and packages them into vesicles destined for lysosomes, melanosomes, and other lysosome-related organelles. The BLOC-1 complex acts upstream of AP-3 to facilitate cargo recognition. Disruption of AP3S1 prevents functional AP-3 complex assembly, leading to aberrant sorting of these cargoes, mislocalization of lysosomal membrane proteins, and downstream defects in lysosome biogenesis and melanosome maturation. The resulting trafficking failure mirrors molecular defects observed in Hermansky-Pudlak syndrome type 2 (HPS2).

In the HEK293T background, AP3S1 knockout causes misdirection of lysosomal membrane proteins to the cell surface and impairs the formation of functional lysosome-related structures. This model recapitulates key cellular phenotypes of HPS2, including defective dense granule biogenesis and LAMP-1 trafficking anomalies. The HEK293T system offers robust protein expression and ease of genetic manipulation, enabling complementation experiments, co-expression studies, and epistasis analyses with other trafficking regulators. The polyclonal nature of the knockout avoids clonal-specific artifacts, providing a reliable platform for dissecting the molecular requirements of AP-3-mediated sorting pathways.

This polyclonal knockout population is ideally suited for vesicle trafficking assays, lysosome biogenesis studies, and disease modeling of HPS2. Representative experimental approaches include Western blotting to detect AP-3 subunit loss, immunofluorescence microscopy to monitor LAMP-1 subcellular distribution, co-immunoprecipitation to evaluate complex formation, and pulse-chase trafficking assays to measure cargo transport kinetics. Additionally, the pooled format supports high-throughput phenotypic screens and pooled functional genomics approaches. For detailed product information, ordering, and technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)